TOVX - Theriva Biologics, Inc.
0.1808
-0.004 -1.991%
Share volume: 1,664,623
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
-0.02%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-12-2024 | 03-06-2025 | 05-14-2025 | 08-11-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 5.036 M | 4.579 M | 4.417 M | 13.132 M | 4.440 M | |
| Selling general and admin | 2.302 M | 1.694 M | 1.449 M | 11.179 M | 1.889 M | |
| Research and development | 2.734 M | 2.885 M | 2.968 M | 1.953 M | 2.551 M | |
| Total expenses | 7.887 M | 4.579 M | 4.417 M | 13.132 M | 4.440 M | |
| -41.94% | -3.54% | 197.31% | -66.19% | |||
| Operating income | -7.887 M | -4.579 M | -4.417 M | -13.132 M | -4.440 M | |
| Ebit | -7.884 M | -4.584 M | -4.420 M | -13.112 M | -4.426 M | |
| Pretax income | -7.726 M | -4.446 M | -4.324 M | -13.058 M | -4.361 M | |
| -42.45% | -2.74% | 201.99% | -66.60% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.726 M | -4.446 M | -4.324 M | -13.058 M | -4.361 M | |
| 42.45% | 2.74% | -201.99% | 66.60% |